ArticleExperimental hematology & oncology2024

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.

Willem Daneels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.